Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingApr 8, 2026Prazosin Hydrochloride CapsulescGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.Appco Pharma LLC · D-0419-2026Class IIOngoingApr 8, 2026Artificial Tears Sterile Lubricant Eye DropsLack of Assurance of SterilityK.C. Pharmaceuticals, Inc · D-0416-2026Class IIOngoingApr 8, 2026STERILE EYE DROPS SOOTHING TEARSLack of Assurance of SterilityK.C. Pharmaceuticals, Inc · D-0415-2026Class IIOngoingApr 8, 2026Sterile EYE DROPS REDNESS LUBRICANTLack of Assurance of SterilityK.C. Pharmaceuticals, Inc · D-0414-2026Class IIOngoingApr 8, 2026Sterile Eye Drops ORIGINAL FORMULALack of Assurance of SterilityK.C. Pharmaceuticals, Inc · D-0413-2026Class IIOngoingApr 8, 2026Ultra Lubricating Eye DropsLack of Assurance of SterilityK.C. Pharmaceuticals, Inc · D-0412-2026Class IIOngoingApr 8, 2026Dry Eye Relief Eye DropsLack of Assurance of SterilityK.C. Pharmaceuticals, Inc · D-0411-2026Class IIOngoingApr 8, 2026EYE DROPS Advanced ReliefLack of Assurance of SterilityK.C. Pharmaceuticals, Inc · D-0410-2026Class IIOngoingApr 8, 2026Sterile EYE DROPS ACLack of Assurance of SterilityK.C. Pharmaceuticals, Inc · D-0409-2026Class IIOngoingApr 8, 2026traMADol Hydrochloride TabletsFailed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long...Amneal Pharmaceuticals, LLC · D-0408-2026Class IIOngoingApr 1, 2026Meclizine Hydrochloride TabletsFailed tablet specifications.Amerisource Health Services LLC · D-0418-2026Class IIOngoingApr 1, 2026Octreotide Acetate for Injectable SuspensionLack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.Teva Pharmaceuticals USA, Inc · D-0406-2026Class IIOngoingApr 1, 2026Octreotide Acetate for Injectable SuspensionLack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.Teva Pharmaceuticals USA, Inc · D-0405-2026Class IIOngoingApr 1, 2026Octreotide Acetate for Injectable SuspensionLack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.Teva Pharmaceuticals USA, Inc · D-0404-2026Class IIOngoingApr 1, 2026Levothyroxine Sodium Tablets USP 150 mcgSubpotent DrugMacleods Pharma USA, Inc · D-0403-2026Class IIOngoingApr 1, 2026CUROSURFLack of Assurance of SterilityChiesi USA, Inc. · D-0402-2026Class IIIOngoingApr 1, 2026Gelatin Capsule Pack for use with the Sodium Iodide I-131 KitFailed Tablet/Capsule SpecificationsRadnostix · D-0401-2026Class IOngoingMar 25, 2026Webcol Alcohol Prep padNon-Sterility: microbial contamination identified as Paenibacillus phoenicisCardinal Health 200, LLC · D-0528-2026Class IIOngoingMar 25, 2026Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*Lack of Assurance of SterilityApotex Corp. · D-0407-2026Class IIOngoingMar 25, 2026Dexamethasone Sodium Phosphate InjectionFailed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these...Somerset Therapeutics LLC · D-0398-2026Class IIIOngoingMar 25, 2026Pitavastatin TabletsPresence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mgAnnora Pharma Private Limited · D-0391-2026Class IIOngoingMar 25, 2026Children's Ibuprofen Oral SuspensionPresence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.Strides Pharma Inc · D-0390-2026Class IIOngoingMar 18, 2026Icosapent Ethyl CapsulesFailed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.Zydus Pharmaceuticals (USA) Inc · D-0400-2026Class IIOngoingMar 11, 2026AmnesteemFailed Dissolution SpecificationsMylan Pharmaceuticals Inc · D-0399-2026Class IOngoingMar 11, 2026MR. 7 SUPER 700000 capsulesMarketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafilStuffbyNainax · D-0397-2026Class IOngoingMar 11, 2026Mojo Max Fusion XXXMarketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).Mohamed Hagar · D-0396-2026Class IIOngoingMar 11, 2026Tirzepatide InjLack of Assurance of SterilityNew Life Pharma LLC · D-0395-2026Class IIOngoingMar 11, 2026Tirzepatide InjLack of Assurance of SterilityNew Life Pharma LLC · D-0394-2026Class IIOngoingMar 11, 2026Semaglutide InjLack of Assurance of SterilityNew Life Pharma LLC · D-0393-2026Class IIOngoingMar 11, 2026Semaglutide InjLack of Assurance of SterilityNew Life Pharma LLC · D-0392-2026Class IIOngoingMar 11, 2026Sodium IodidePresence of Particulate Matter: Due to production issuesRadnostix · D-0389-2026Class IOngoingMar 11, 2026SILINTAN 25/pillsMarketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.ANTHONY TRINH, 123Herbals LLC · D-0388-2026Class IIOngoingMar 11, 2026MAXIMUM, ZONE 2Stability Data Does Not Support Expiry Date.HTO Nevada Inc. dba Kirkman · D-0387-2026Class IIOngoingMar 11, 2026MAXIMUM, ZONE 1Stability Data Does Not Support Expiry Date.HTO Nevada Inc. dba Kirkman · D-0386-2026Class IIOngoingMar 11, 2026FIVE-STARStability Data Does Not Support Expiry Date.HTO Nevada Inc. dba Kirkman · D-0385-2026Class IIOngoingMar 11, 2026Product label: Temozolomide CapsulesFailed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testingRising Pharma Holding, Inc. · D-0384-2026Class IIOngoingMar 11, 2026Midodrine Hydrochloride TabletsDefective container; inadequately sealed blister packaging.The Harvard Drug Group LLC · D-0383-2026Class IIIOngoingMar 11, 2026Nilotinib CapsulesFailed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.Cipla USA, Inc. · D-0382-2026Class IIIOngoingMar 11, 2026Nilotinib CapsulesFailed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.Cipla USA, Inc. · D-0381-2026Class IIOngoingMar 11, 2026SemaglutideCGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distributionHarbin Jixianglong Biotech Co., Ltd. · D-0380-2026

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.